Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
A Stock Chart & Stats
$111.30
-$0.52(-0.38%)
At close: 4:00 PM EST
$111.30
-$0.52(-0.38%)
Day’s Range― - ―
52-Week Range$96.43 - $160.27
Previous CloseN/A
Volume231.77K
Average Volume (3M)2.46M
Market Cap
$31.45B
Enterprise Value$33.15B
Total Cash (Recent Filing)$1.76B
Total Debt (Recent Filing)$3.35B
Price to Earnings (P/E)31.0
Beta0.99
Next Earnings
May 26, 2026EPS Estimate
1.41Next Dividend Ex-DateN/A
Dividend Yield0.72%
Share Statistics
EPS (TTM)1.36
Shares Outstanding282,602,330
10 Day Avg. Volume2,234,439
30 Day Avg. Volume2,460,202
Financial Highlights & Ratios
PEG Ratio9.41
Price to Book (P/B)6.14
Price to Sales (P/S)5.96
P/FCF Ratio35.95
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue4.69
Enterprise Value/Gross Profit8.98
Enterprise Value/Ebitda18.18
Forecast
1Y Price Target
$163.62Price Target Upside47.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)5.97
Revenue Forecast (FY)$7.39B
Bulls Say, Bears Say
Bulls Say
Consumables And Biopharma DemandStrong demand for consumables and orders from contract drug manufacturers focused on oligonucleotides, peptides and mRNA supports stable, repeatable revenue streams.
Margin Improvement And OutlookMargin recovery driven by the Ignite efficiency program combined with management's reiterated outlook for growth and operating margin expansion points to improving profitability.
Product Replacement CycleAn ongoing replacement cycle for liquid chromatography and mass spectrometry, supported by recent product launches, is expected to sustain instrument demand and drive equipment revenue.
Bears Say
End Market WeaknessSoftness in cell analysis and genomics, plus ongoing pressure in academic and government spending and weaker Americas demand, could limit revenue recovery and dampen upside expectations.
Supply Chain DisruptionsShipping delays and weather-related disruptions that delayed orders and service work caused a sales and earnings shortfall and increased revenue and service backlog risk.
Tariff And Regional CompetitionTariff-related cost pressures and dynamic trade policies, together with local competition in China, can squeeze gross margins and weaken growth in key regional markets.
Agilent News
A FAQ
What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was $96.43 and its highest was $160.27 in the past 12 months.
What is Agilent’s market cap?
Agilent’s market cap is $31.45B.
When is Agilent’s upcoming earnings report date?
Agilent’s upcoming earnings report date is May 26, 2026 which is in 66 days.
How were Agilent’s earnings last quarter?
Agilent released its earnings results on Feb 25, 2026. The company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by -$0.01.
Is Agilent overvalued?
According to Wall Street analysts Agilent’s price is currently Undervalued.
Does Agilent pay dividends?
Agilent pays a Quarterly dividend of $0.255 which represents an annual dividend yield of 0.72%. See more information on Agilent dividends here
What is Agilent’s EPS estimate?
Agilent’s EPS estimate is 1.41.
How many shares outstanding does Agilent have?
Agilent has 282,602,330 shares outstanding.
What happened to Agilent’s price movement after its last earnings report?
Agilent reported an EPS of $1.36 in its last earnings report, missing expectations of $1.37. Following the earnings report the stock price went down -3.007%.
Which hedge fund is a major shareholder of Agilent?
Currently, no hedge funds are holding shares in A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilent Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$163.62 (47.01% Upside)
$163.62 (47.01% Upside)
Blogger Sentiment
Bullish
A Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 6.5%
Last 30 Days ▲ 6.5%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.72%
12-Months-Change
Fundamentals
Return on Equity
19.73%
Trailing 12-Months
Asset Growth
7.55%
Trailing 12-Months
Company Description
Agilent
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
A Company Deck
A Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid top-line growth, maintained full‑year guidance, strong product and commercial momentum (notably in pharma/GLP‑1, CAM/advanced materials, Infinity III and Pro iQ), healthy cash generation and clear benefits from the Ignite operating program. Near-term headwinds—tariff-driven gross margin pressure, an isolated weather disruption (~$10M), and pockets of softness in academia/government, cell analysis and certain smaller end markets—were acknowledged but framed as manageable through pricing, supply‑chain actions and Ignite-led savings. Management maintained disciplined capital allocation, reiterated mid‑term growth drivers (replacement cycles, CDMO expansion, reshoring of semiconductor/pharma manufacturing) and emphasized integration/M&A readiness. Overall, positive execution and momentum outweigh the identified challenges.View all A earnings summariesA Revenue Breakdown
39.23% Life Sciences and Diagnostics Markets
41.85% Agilent CrossLab
18.91% Applied Markets
A Stock 12 Month Forecast
Average Price Target
$163.62
▲(47.01% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
27.76% Mutual Funds
19.78% Other Institutional Investors
26.34% Public Companies and Individual Investors